CREDIT SUISSE AG/ - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$260,478
+0.3%
16,486
-3.9%
0.00%
Q2 2023$259,742
+44.5%
17,156
+38.4%
0.00%
Q1 2023$179,787
+50.9%
12,399
+40.7%
0.00%
Q4 2022$119,1258,811
+146750.0%
0.00%
Q2 2022$060.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders